DXP Stock Hits New 52-Week High (DXPE)

NEW YORK ( TheStreet) -- DXP (Nasdaq: DXPE) hit a new 52-week high Friday as it is currently trading at $31.75, above its previous 52-week high of $31.48 with 26,390 shares traded as of 10:25 a.m. ET. Average volume has been 87,600 shares over the past 30 days.

DXP has a market cap of $421.1 million and is part of the services sector and wholesale industry. Shares are up 27.8% year to date as of the close of trading on Thursday.

DXP Enterprises, Inc. engages in distributing maintenance, repair, and operating (MRO) products, equipment, and service to industrial customers in the United States. The company has a P/E ratio of 16.1, equal to the average wholesale industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates DXP as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full DXP Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge

Starbucks Slides After 'Unacceptable' Performance Leads to U.S. Store Closures

Starbucks Slides After 'Unacceptable' Performance Leads to U.S. Store Closures

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'